S. Gail Eckhardt
Direktor/Vorstandsmitglied bei EXELIXIS, INC.
Aktive Positionen von S. Gail Eckhardt
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SYROS PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 08.09.2020 | - |
Independent Dir/Board Member | - | - | |
EXELIXIS, INC. | Direktor/Vorstandsmitglied | 05.01.2024 | - |
Independent Dir/Board Member | 05.01.2024 | - | |
OncoTEX Inc. | Direktor/Vorstandsmitglied | 01.01.2022 | - |
Association of American Cancer Institutes
Association of American Cancer Institutes Miscellaneous Commercial ServicesCommercial Services Association of American Cancer Institutes operates as a membership association of academic and freestanding cancer research centers in the United States. It comprises 98 cancer research centers. The company is headquartered in Pittsburgh, PA. | Direktor/Vorstandsmitglied | 20.10.2019 | - |
Karriereverlauf von S. Gail Eckhardt
Ehemalige bekannte Positionen von S. Gail Eckhardt
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Dell Medical School | Corporate Officer/Principal | 01.01.2017 | 01.01.2023 |
NUGENEREX IMMUNO-ONCOLOGY, INC. | Direktor/Vorstandsmitglied | 01.03.2020 | 01.05.2021 |
Independent Dir/Board Member | 01.03.2020 | 01.05.2021 | |
The University of Colorado School of Medicine | Corporate Officer/Principal | 01.01.1999 | 01.01.2017 |
The University of Colorado School of Medicine | Corporate Officer/Principal | 01.01.2006 | 01.01.2014 |
The University of Texas at Austin | Corporate Officer/Principal | - | - |
░░░░░░ ░░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░░░ ░░ ░░░░░░░░ ░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░ ░░░░░░░ ░ ░░░░░░░░ ░░░░░░ ░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░░░ ░░ ░░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░ ░░░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Ausbildung von S. Gail Eckhardt
University of Texas Medical Branch | Doctorate Degree |
Stephen F. Austin State University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 17 |
2 |
Operativ
Corporate Officer/Principal | 11 |
Director/Board Member | 6 |
Independent Dir/Board Member | 3 |
Sektoral
Consumer Services | 9 |
Health Technology | 4 |
Commercial Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
SYROS PHARMACEUTICALS, INC. | Health Technology |
EXELIXIS, INC. | Health Technology |
Private Unternehmen | 7 |
---|---|
5AM Venture Management LLC
5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US. | Finance |
Clinical Research Advantage, Inc.
Clinical Research Advantage, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Research Advantage, Inc. provides research services to the pharmaceutical companies and clinical research organizations. The company was founded in 1992 and is headquartered in Tempe, AZ. | Commercial Services |
Cancer Therapy & Research Center Endowment | Health Services |
Association of American Cancer Institutes
Association of American Cancer Institutes Miscellaneous Commercial ServicesCommercial Services Association of American Cancer Institutes operates as a membership association of academic and freestanding cancer research centers in the United States. It comprises 98 cancer research centers. The company is headquartered in Pittsburgh, PA. | Commercial Services |
NuGenerex Immuno-Oncology, Inc.
NuGenerex Immuno-Oncology, Inc. BiotechnologyHealth Technology NuGenerex Immuno-Oncology, Inc. is an oncology company focuses on the modulation of the immune system to treat cancer. It develops immunotherapeutic products and vaccines based on proprietary, patented platform technology, Ii-Key. The Ii-Key is a peptide derived from the major histocompatibility complex (MHC) class II associated invariant chain that regulates the formation, trafficking, and antigen-presenting functions of MHC class II complexes, essential for the activation of T cells in the immune response. The company was founded on October 8, 1993 and is headquartered in Miramar, FL. | Health Technology |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Health Services |
OncoTEX Inc. |
- Börse
- Insiders
- S. Gail Eckhardt
- Erfahrung